在急性髓细胞性白血病aml和急性淋巴细胞性白血病all中，原始的急性白血病细胞进展、形成多达上亿个的白血病细胞。
In acute myelogenous leukemia (AML) and acute lymphocytic leukemia (ALL), the original acute leukemia cell goes on to form about a trillion more leukemia cells.
在高倍镜下，见到的是急性髓母细胞白血病骨髓。在右侧中心处有一个孤立巨核细胞。
At high power, the bone marrow of a patient with acute myelogenous leukemia is seen here. There is one lone megakaryocyte at the right center.
目的：探讨CD44单克隆抗体A3D8对人急性髓系白血病细胞株HL-60细胞增殖分化影响的分子作用机制。
Objective:To investigate the molecular mechanism of the effect of A3D8, an anti-CD44 monoclonal antibody on proliferation and differentiation of human HL-60 cells.
研究方法：用流式细胞仪检测30例急性髓性白血病的P_(170)和活化t细胞的表达。
Methods: Flow cytometer (FCM) was used in detection of the expression of P170 and active t cell in leukemic cells from 30 cases of AML patients.
“慢性”白血病少有或几乎没有母细胞。与急性白血病相比，“慢性淋巴细胞性白血病”和“慢性髓细胞性白血病”通常进程相对缓慢。
"Chronic" leukemias have few or no blast cells. "chronic lymphocytic leukemia" and "chronic myelogenous leukemia" usually progress slowly compared to acute leukemias.
急性髓细胞白血病的发生始于骨髓中某个细胞的病变。
AML starts with a change to a single cell in the bone marrow.
对于急性髓细胞白血病，白血病细胞通常是指原始细胞。
With AML, the leukemic cells are often referred to as blast cells.
造血干细胞移植(有时也称为骨髓移植)，是治疗急性髓细胞白血病的一种手段。
A stem cell transplant (sometimes called a bone marrow transplant) is a treatment used for some patients who have AML.
【译】结合在细胞遗传学正常的急性髓细胞性白血病的分子和复发和生存的预后指标。
Combined Molecular and Clinical Prognostic Index for Relapse and Survival in Cytogenetically Normal Acute Myeloid Leukemia.
结果显示，在23例急性髓细胞白血病患者中17例患者的骨髓白血病细胞上有IDO的表达；
The results showed that IDO expression was found in 17 out of 23 cases of acute myeloid leukemia cells;
预激方案；急性髓细胞性白血病；粒细胞集落刺激因子；
Priming induction regimen; Acute myeloid leukemia(AML); Granulocyte colony stimulating factor;
目的：探讨WT1基因及其蛋白产物在急性髓细胞白血病（AML）细胞的表达及临床意义。
Objective:To explore the expression and significance of the WT1 gene and proteins in patients with acute myelocytic leukemia(AML).
方法：25例急性白血病患者接受HLA相合同胞的异基因外周血造血干细胞移植，其中急性髓系白血病20例，急性淋巴细胞白血病5例。
METHODS: a total of 25 patients with acute leukemia received HLA-identical sibling allo-PBSCT. All cases included 20 cases with acute myeloid leukemia and 5 cases with acute lymphocytic leukemia.
与急性髓细胞性白血病相比，急性淋巴细胞性白血病细胞免疫功能更为低下。
Compared with acute myelogenous leukemia, patients with acute lymphoblastic leukemia had more poor cellular immune function.
急性髓细胞白血病的分型也会影响其治愈率，如急性早幼粒细胞白血病的治愈率就相对较高。
Patients with certain subtypes of AML, such as acute promyelocytic leukemia (APL) have a higher chance of cure.
目的观察131I-GMCSF诱导HL60/ADM细胞凋亡，探讨其诱导HL60/ADM细胞凋亡的机制，比较131I-GMCSF对HL60/ADM细胞和HL60细胞的细胞毒作用，为其临床治疗难治性或复发性急性髓细胞性白血病提供实验依据。
Objective: To compare the cytotoxicity of HL60/ADM cells and HL60 cells treated with 131I-GMCSF and to investigate the mechanism of the apoptosis of HL-60/ADM cells induced by 131I-GMCSF.
目的观察131I-GMCSF诱导HL60/ADM细胞凋亡，探讨其诱导HL60/ADM细胞凋亡的机制，比较131I-GMCSF对HL60/ADM细胞和HL60细胞的细胞毒作用，为其临床治疗难治性或复发性急性髓细胞性白血病提供实验依据。
Objective: To compare the cytotoxicity of HL60/ADM cells and HL60 cells treated with 131I-GMCSF and to investigate the mechanism of the apoptosis of HL-60/ADM cells induced by 131I-GMCSF.
应用推荐